Total Payments
$19,854
2024 Payments
$10,018
Companies
34
Transactions
690
Medicare Patients
17,548
Medicare Billing
$2.3M
Payment Breakdown by Category
Food & Beverage$11,719 (59.0%)
Other$8,081 (40.7%)
Travel$32.16 (0.2%)
Education$21.56 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,719 | 684 | 59.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,081 | 2 | 40.7% |
| Travel and Lodging | $32.16 | 1 | 0.2% |
| Education | $21.56 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $8,470 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $2,032 | 117 | $0 (2024) |
| Amgen Inc. | $1,487 | 96 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,449 | 109 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $840.09 | 67 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $836.66 | 62 | $0 (2024) |
| PFIZER INC. | $593.98 | 38 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $476.96 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $467.89 | 29 | $0 (2024) |
| Amarin Pharma Inc. | $384.30 | 30 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,018 | 101 | Novo Nordisk Inc ($8,360) |
| 2023 | $1,284 | 47 | Impulse Dynamics (USA) Inc. ($291.85) |
| 2022 | $1,077 | 68 | CVRx, Inc. ($185.94) |
| 2021 | $1,395 | 73 | Janssen Pharmaceuticals, Inc ($587.95) |
| 2020 | $1,453 | 89 | Janssen Pharmaceuticals, Inc ($319.46) |
| 2019 | $2,318 | 153 | Amgen Inc. ($586.04) |
| 2018 | $1,131 | 88 | Amgen Inc. ($350.57) |
| 2017 | $1,179 | 71 | Novartis Pharmaceuticals Corporation ($389.09) |
All Payment Transactions
690 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $5.87 | General |
| Category: Cardiovascular | ||||||
| 12/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Cardiology | ||||||
| 12/08/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $3.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/26/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.69 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.66 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.67 | General |
| Category: Cardiovascular | ||||||
| 10/30/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.69 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/23/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $107.63 | General |
| 10/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: Obesity | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $1.51 | General |
| Category: Obesity | ||||||
| 10/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Cardio-renal | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/23/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: Obesity | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: NEUROLOGY | ||||||
| 09/06/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 4,782 | 6,575 | $1.9M | $777,148 |
| 2022 | 34 | 4,466 | 5,947 | $1.4M | $554,213 |
| 2021 | 33 | 4,328 | 5,705 | $1.2M | $501,518 |
| 2020 | 30 | 3,972 | 5,040 | $1.2M | $470,045 |
Total Patients
17,548
Total Services
23,267
Medicare Billing
$2.3M
Procedure Codes
139
All Medicare Procedures & Services
139 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 144 | 144 | $705,600 | $314,812 | 44.6% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 144 | 155 | $158,400 | $96,038 | 60.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 412 | 556 | $138,930 | $55,404 | 39.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 280 | 281 | $154,142 | $46,525 | 30.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 221 | 275 | $93,500 | $36,481 | 39.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 168 | 672 | $43,680 | $28,261 | 64.7% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 35 | 36 | $86,400 | $27,347 | 31.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 160 | 168 | $71,904 | $23,935 | 33.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 66 | 362 | $43,440 | $19,205 | 44.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 302 | 305 | $43,310 | $17,076 | 39.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 32 | 32 | $30,752 | $12,519 | 40.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 118 | 158 | $21,014 | $10,596 | 50.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 571 | 892 | $40,140 | $9,991 | 24.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 76 | 94 | $19,082 | $9,306 | 48.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 50 | 215 | $15,050 | $8,693 | 57.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 914 | 1,084 | $27,100 | $7,066 | 26.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 39 | 39 | $15,444 | $6,123 | 39.6% |
| G0166 | External counterpulsation, per treatment session | Office | 2023 | 18 | 60 | $19,200 | $5,615 | 29.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 51 | 51 | $14,943 | $5,600 | 37.5% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 177 | 177 | $25,311 | $5,455 | 21.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $9,240 | $3,992 | 43.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 207 | 207 | $24,840 | $3,403 | 13.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $8,710 | $3,384 | 38.9% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 56 | 60 | $16,740 | $3,335 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 44 | $7,700 | $3,242 | 42.1% |
About Dr. Mitchell Rosenberg, MD
Dr. Mitchell Rosenberg, MD is a Cardiovascular Disease healthcare provider based in Haddon Heights, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477504017.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Rosenberg, MD has received a total of $19,854 in payments from pharmaceutical and medical device companies, with $10,018 received in 2024. These payments were reported across 690 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($11,719).
As a Medicare-enrolled provider, Rosenberg has provided services to 17,548 Medicare beneficiaries, totaling 23,267 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 139 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Haddon Heights, NJ
- Active Since 05/15/2006
- Last Updated 12/10/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1477504017
Products in Payments
- Ozempic (Drug) $3,625
- XARELTO (Drug) $2,032
- ELIQUIS (Drug) $1,151
- ENTRESTO (Drug) $982.70
- Corlanor (Drug) $865.36
- LifeVest (Device) $836.66
- Repatha (Biological) $614.43
- LEQVIO (Drug) $466.61
- Vascepa (Drug) $384.30
- Barostim Neo System (Device) $375.23
- BRILINTA (Drug) $299.13
- OPTIMIZER (Device) $291.85
- VERQUVO (Drug) $208.44
- WATCHMAN FLX (Device) $194.11
- PRALUENT (Drug) $174.29
- Optimizer (Device) $173.17
- NEXLETOL (Drug) $169.94
- remede System (Device) $168.83
- MULTAQ (Drug) $158.05
- HeartMate (Device) $144.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Haddon Heights
Dr. Dilip Viswanath, Md, MD
Cardiovascular Disease — Payments: $224,204
Cardiovascular Disease $224,204
Dr. Steven Levi, Md, MD
Cardiovascular Disease — Payments: $73,173
Cardiovascular Disease $73,173
Andreas Pavlides, Md, MD
Cardiovascular Disease — Payments: $67,739
Cardiovascular Disease $67,739
Dr. Adam Levine, D.o, D.O
Cardiovascular Disease — Payments: $62,722
Cardiovascular Disease $62,722
Dr. Vijayendra Verma, Md, MD
Cardiovascular Disease — Payments: $38,237
Cardiovascular Disease $38,237
Dr. Sanford Gips, Md, MD
Cardiovascular Disease — Payments: $25,440
Cardiovascular Disease $25,440